[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343203-105":59,"doc-detail-343203-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","integrated-multi-omics-characterization-of-smad4-mutant-colorectal-cancer","Integrated multi-omics characterization of SMAD4 mutant colorectal cancer","","Colorectal cancer is a major global health threat. SMAD4, a member of the SMAD family involved in TGF-β and BMP signaling, is often mutated, yet the molecular consequences of SMAD4 mutations in colon cancer remain unclear. By integrating multi-omics data from SMAD4-mutant patients, the study delineates mutation profiles, identifies missense mutations as predominant, links SMAD4 mutation to poorer survival, and reveals immune-cell reductions in tumor tissues, altered gene sets, and distinct drug sensitivities versus non-mutant cases.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrated-multi-omics-characterization-of-smad4-mutant-colorectal-cancer/343203/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrated-multi-omics-characterization-of-smad4-mutant-colorectal-cancer/343203.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main purpose of integrating multi-omics data in this study?","Question",{"text":113,"@type":114},"To characterize transcriptome, immune features, and drug sensitivity patterns in patients with SMAD4 mutant colorectal cancer and compare them with non-mutant groups.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What mutation type of SMAD4 is most common among the mutant patients?",{"text":118,"@type":114},"A missense mutation is described as the most common mutant type of SMAD4.",{"name":120,"@type":111,"acceptedAnswer":121},"How do SMAD4 mutations relate to patient outcomes and tumor immunity?",{"text":122,"@type":114},"Patients with SMAD4 mutations have worse survival, and tumor tissues show reductions in immune cells such as CD4+ memory T cells and memory B cells.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},343203,1790182133,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Analysis  \nIntegrated multi‑omics characterization of SMAD4 mutant colorectal cancer  \nDanyi Zhao1 · Yanjun Qu1 · Na Gao2 · Tao Wu1  \nReceived: 7 April 2024 / Accepted: 23 August 2024  \n© The Author(s) 2024 OPEN  \nAbstract  \nColorectal cancer is one of the most common cancers around the world, which is a severe threat to people’s health. SMAD4 belongs to the dwarfin/SMAD family, which plays a crucial role inTGF-β and BMP signal pathways. As the molecular characterization of colon cancer patients following SMAD4 mutations remains unclear, we integrated multi-omics data of SMAD4 mutant patients to reveal the profile of molecular characterization of SMAD4 mutation. A missense mutation is the most common mutant type of SMAD4 . Patients with SMAD4 mutation had worse survival. Tumor tissues from patients carrying the SMAD4 mutation showed a reduction in various immune cells, such as CD4 + memory T cells and memory B cells. Many differential genes were identified compared to the SMAD4 mutation-free group and could be significantly enriched for tumor-and immune-related signaling pathways. In addition, the mutant group had different drug sensitivities than the non-mutant group.  \nKeywords Colorectal cancer · SMAD4 · Multi-omics data · Single cell RNA sequence  \n1 Introduction  \nSMAD4 gene, also known as the DPC4 gene, is located on the long arm of chromosome 18 and encodes a protein called SMAD4. It is a tumor suppressor gene that helps prevent cancer development by regulating cell growth and differentiation, and it is often mutated in various types of cancer [1] . SMAD4 is a transcription factor that plays a critical role in the transforming growth factor-beta (TGF-β) signaling pathway and is involved in multiple cellular processes, including cell proliferation, differentiation, apoptosis, and migration [2]. When TGF-β ligands bind to their receptors, SMAD4 is activated and translocated into the nucleus, where it acts as a transcription factor, regulating the expression of target genes [3]. Loss-of-function mutations in the SMAD4 gene have been reported in several types of cancer, including pancreatic, colorectal, gastric, and ovarian cancers [4–8]. These mutations decrease SMAD4 activity, resulting in dysregulated TGF-β signaling and aberrant cell growth and proliferation.  \nDanyi Zhao andYanjun Qu contributed equally to this work. Na Gao and Tao Wu were corresponding authors for the study.  \nSupplementary Information The online version contains supplementary material available at [https://doi.org/10.1007/s12672-024-](https://doi.org/10.1007/s12672-024-)[ ](https://doi.org/10.1007/s12672-024-)[01268-7](01268-7.)[.](01268-7.)  \n* Na Gao, [gaona2001@163.com](gaona2001@163.com); * Tao Wu, [wuyihong97@126.com](wuyihong97@126.com); Danyi Zhao, [zhaodanyi1978@163.com](zhaodanyi1978@163.com); Yanjun Qu, [quyanjun-1988@163.com |](quyanjun-1988@163.com |1Department of Medical Oncology)[1](quyanjun-1988@163.com |1Department of Medical Oncology)[Department of Medical Oncology](quyanjun-1988@163.com |1Department of Medical Oncology), The Second Affiliated Hospital of Dalian Medical University, Dalian, China. 2Department of Obstetrics and Gynecology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.  \nDiscover Oncology  \n(2024) 15:386  \n| [https://doi.org/10.1007/s12672-024-01268-7](https://doi.org/10.1007/s12672-024-01268-7)  \nSMAD4 gene mutations are prevalent in tumors. Of these, approximately 10–30% of colorectal cancer cases are found to carry mutations in the SMAD4 gene [9] . Similarly, up to 55% of pancreatic cancer patients harbor mutations in this gene [10]. This mutation makes the disease more aggressive and is associated with a poorer prognosis [11, 12]. However, SMAD4 mutations may also have therapeutic implications. Preclinical studies have shown that re-expression of functional SMAD4 in SMAD4-deficient cancer cells can lead to growth suppression and sensitization to chemotherapy [13] . Therefore, strategies ","cbCaioktmQAw3fb1","https://ap.wps.com/l/cbCaioktmQAw3fb1","pdf",1127827,"English","# Abstract\n# 1 Introduction\n# 2 Materials and methods\n## 2.1 Data acquirement and analysis","[{\"question\":\"What is the main purpose of integrating multi-omics data in this study?\",\"answer\":\"To characterize transcriptome, immune features, and drug sensitivity patterns in patients with SMAD4 mutant colorectal cancer and compare them with non-mutant groups.\"},{\"question\":\"What mutation type of SMAD4 is most common among the mutant patients?\",\"answer\":\"A missense mutation is described as the most common mutant type of SMAD4.\"},{\"question\":\"How do SMAD4 mutations relate to patient outcomes and tumor immunity?\",\"answer\":\"Patients with SMAD4 mutations have worse survival, and tumor tissues show reductions in immune cells such as CD4+ memory T cells and memory B cells.\"}]","Integrated multi-omics characterization of SMAD4 mutant colorectal cancer | PDF",1790050270,25,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/40c3e056e55ff20c5014cc5e89aa0af7.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd5198f5bd0b75282d4b4489c9f39994.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d2d96e9ba92ad7ceef70f85ea6168ef.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7614211923bb26d8a9045c7d0694929b.webp",980,1301]